Drawing for THERALASE

USPTO serial 97343587

THERALASE

Reviewed by CopyMark Law Group

Status 651
Filing date
Status date
Registration date
—
Examiner
DAVIS, MARC STEPHEN
Law office
TMO LAW OFFICE 122

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERALASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Tener, Esq.

David M. Tener, Esq. CAESAR RIVISE, PC500 Office Center DriveSuite 400Fort Washington, PA 19034

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; tumor suppressing agents; photosensitizing agents for photodynamic therapy, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill pathogens; disinfectant compositions activatable by light and/or ionizing radiation to kill pathogens; photosensitizing compositions in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cellsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 14, 2026GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 14, 2026CNSISUSPENSION INQUIRY WRITTEN—
Oct 6, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 8, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 8, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 8, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 8, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 8, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 15, 2026GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 15, 2026GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 15, 2026CNSISUSPENSION INQUIRY WRITTEN—
Dec 24, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 23, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 23, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jun 23, 2025CNSLSUSPENSION LETTER WRITTEN—
Jun 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 19, 2025GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 19, 2025GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 19, 2025CNSISUSPENSION INQUIRY WRITTEN—
Jan 24, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 17, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 17, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Apr 17, 2024CNSLSUSPENSION LETTER WRITTEN—
Apr 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2024ALIEASSIGNED TO LIE—
Nov 28, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 29, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 29, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 29, 2023CNSISUSPENSION INQUIRY WRITTEN—
Aug 8, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 24, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 24, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jan 24, 2023CNSLSUSPENSION LETTER WRITTEN—
Jan 18, 2023DOCKASSIGNED TO EXAMINER—
Apr 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 5, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance